State Street
CGEN icon

State Street’s Compugen CGEN Stock Holding History

State Street’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$885K Buy
415,366
+21,564
+5% +$41.9K ﹤0.01% 3516
2025
Q4 		$603K Buy
393,802
+14,701
+4% +$24.4K ﹤0.01% 3631
2025
Q3 		$557K Buy
379,101
+27,922
+8% +$41.5K ﹤0.01% 3638
2025
Q2 		$625K Buy
351,179
+7,046
+2% +$10.4K ﹤0.01% 3577
2025
Q1 		$502K Buy
344,133
+175,457
+104% +$343K ﹤0.01% 3587
2024
Q4 		$258K Buy
168,676
+1,569
+0.9% +$2.55K ﹤0.01% 3786
2024
Q3 		$302K Buy
167,107
+2,370
+1% +$4.33K ﹤0.01% 3712
2024
Q2 		$277K Buy
164,737
+2,679
+2% +$5.58K ﹤0.01% 3729
2024
Q1 		$418K Sell
162,058
-2,979
-2% -$6.94K ﹤0.01% 3697
2023
Q4 		$327K Buy
165,037
+2,755
+2% +$2.41K ﹤0.01% 3754
2023
Q3 		$151K Buy
162,282
+3,591
+2% +$3.95K ﹤0.01% 4006
2023
Q2 		$181K Buy
158,691
+2,923
+2% +$2.55K ﹤0.01% 4036
2023
Q1 		$109K Buy
155,768
+6,639
+4% +$5.46K ﹤0.01% 4300
2022
Q4 		$107K Buy
149,129
+9,110
+7% +$7.95K ﹤0.01% 4350
2022
Q3 		$92K Buy
140,019
+2,677
+2% +$3.78K ﹤0.01% 4489
2022
Q2 		$254K Sell
137,342
-615,168
-82% -$1.33M ﹤0.01% 4098
2022
Q1 		$2.42M Buy
752,510
+68,338
+10% +$231K ﹤0.01% 3492
2021
Q4 		$2.94M Sell
684,172
-1
-0% -$5 ﹤0.01% 3498
2021
Q3 		$4.08M Buy
684,173
+28,777
+4% +$193K ﹤0.01% 3337
2021
Q2 		$5.43M Buy
655,396
+73,010
+13% +$593K ﹤0.01% 3205
2021
Q1 		$5M Buy
582,386
+19,600
+3% +$217K ﹤0.01% 3052
2020
Q4 		$6.82M Buy
562,786
+57,556
+11% +$794K ﹤0.01% 2812
2020
Q3 		$8.21M Buy
505,230
+26,001
+5% +$426K ﹤0.01% 2544
2020
Q2 		$7.2M Buy
479,229
+459,206
+2,293% +$6.2M ﹤0.01% 2581
2020
Q1 		$145K Sell
20,023
-1,457
-7% -$11.4K ﹤0.01% 3595
2019
Q4 		$128K Sell
21,480
-320
-1% -$1.65K ﹤0.01% 3668
2019
Q3 		$92K Buy
+21,800
New +$81.6K ﹤0.01% 3678

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street's CGEN Position: Q1 2026 in Review

State Street increased its Compugen (CGEN) stake by 5.5% in Q1 2026, buying an estimated $41.9K and bringing the position to 415,366 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #3516.

State Street first reported a position in CGEN in Q3 2019 and has held it in 27 quarters since. The position peaked at $8.21M in Q3 2020. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • State Street held 415,366 shares of Compugen worth $885K as of Q1 2026.
  • State Street bought 21,564 Compugen shares in Q1 2026, an estimated $41.9K.
  • Compugen made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3516 holding.
  • State Street first reported a position in Compugen in Q3 2019 and has held it in 27 quarters since.
  • State Street's Compugen position peaked at $8.21M in Q3 2020.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.